Related Experiment Video
Updated: Feb 15, 2026

Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
Mixed dementia: A review of the evidence
Nilton Custodio1,2, Rosa Montesinos1,3, David Lira1,2
1Unidad de Diagnóstico de Deterioro Cognitivo y Prevención de Demencia. Instituto Peruano de Neurociencias. Lima, Perú.
Abstract:
Mixed dementia is the coexistence of Alzheimer's disease and cerebrovascular disease (CVD) in the same demented patient. Currently, its diagnosis and treatment remains a challenge for practitioners. To provide an overview of the epidemiology, pathogenesis, natural history, diagnosis, and therapy of Mixed Vascular-Alzheimer Dementia (MVAD). The literature was reviewed for articles published between 1990-2016 by using the keywords linked to MVAD. Neuropathological studies indicate that MVAD is a very common pathological finding in the elderly with a prevalence about of 22%. The distinction between Alzheimer's dementia and vascular dementia (VD) is complex because their clinical presentation can overlap. There are international criteria for the MVAD diagnosis. The pharmacologic therapy shows modest clinical benefits that are similar among all drugs used in patients with Alzheimer's dementia and VD. The non-pharmacologic therapy includes the rigorous management of cardiovascular risk factors (especially hypertension) and the promotion of a healthy diet. The diagnosis and treatment of MVAD cannot be improved without further studies. Currently available medications provide only modest clinical benefits once a patient has developed MVAD. In subjects at risk, the antihypertensive therapy and healthy diet should be recommend for preventing or slowing the progression of MVAD.
Insights
Mixed dementia, combining Alzheimer's disease and cerebrovascular disease, is common in the elderly. Management focuses on cardiovascular risk factors and healthy diets, as current drug therapies offer limited benefits for this complex condition.
Area of Science:
- Neurology
- Geriatrics
- Pathology
Background:
- Mixed dementia involves coexisting Alzheimer's disease and cerebrovascular disease (CVD).
- Diagnosis and treatment present significant challenges for healthcare professionals.
- Mixed Vascular-Alzheimer Dementia (MVAD) is a prevalent pathological finding in the elderly.
Purpose of the Study:
- To provide a comprehensive overview of Mixed Vascular-Alzheimer Dementia (MVAD).
- To review the epidemiology, pathogenesis, natural history, diagnosis, and therapy of MVAD.
- To synthesize current knowledge on managing this complex dementia subtype.
Main Methods:
- Literature review of articles published between 1990 and 2016.
- Keywords used included "Mixed Vascular-Alzheimer Dementia" and related terms.
- Analysis of neuropathological studies and clinical presentation data.
Main Results:
- MVAD has a prevalence of approximately 22% in the elderly population.
- Clinical differentiation between Alzheimer's dementia and vascular dementia is challenging due to overlapping symptoms.
- Pharmacologic therapies offer modest, similar benefits for both MVAD and individual dementia types.
Conclusions:
- Non-pharmacologic therapy, including managing cardiovascular risk factors (hypertension) and promoting healthy diets, is crucial.
- Current medications provide limited clinical benefits once MVAD is established.
- Antihypertensive therapy and healthy diets are recommended for preventing or slowing MVAD progression in at-risk individuals.
More Related Videos
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
06:48Lexical Decision Task for Studying Written Word Recognition in Adults with and without Dementia or Mild Cognitive Impairment
Published on: June 25, 2019
Related Concept Videos
The Evidence for Evolution
Dementia
The progression of dementia is generally gradual....
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Mixing Concrete
Mixing Time